Live Feeds
● LIVE Updated 1h ago · 37 sources tracked

An experimental fentanyl vaccine showed promise in an early-stage trial

Scripps Research has created an experimental vaccine designed to stop fentanyl overdoses. The treatment aims to block the drug before it can cause a fatal event.

RSS Source map (29)

What changed

The developer of the experimental vaccine is now identified as Scripps Research.

Live updates

  1. Scripps Research develops experimental fentanyl vaccine

    Scripps Research has created an experimental vaccine designed to stop fentanyl overdoses. The treatment aims to block the drug before it can cause a fatal event.

    Still unconfirmed:

    • A new experimental vaccine from Scripps Research could provide a way to prevent fentanyl overdoses.
    confidence 50%

  2. Fentanyl Vaccine Research Seeks Clinical Proof

    Researchers are using antibodies to prevent fentanyl from entering the brain. While the strategy shows promise, the treatment still requires clinical proof.

    Still unconfirmed:

    • An experimental fentanyl vaccine showed promise in an early-stage trial.
    • Antibodies are used to block the drug before it reaches the brain.
    confidence 50%

  3. Scripps Research develops fentanyl vaccine to block overdoses

    An experimental vaccine from Scripps Research aims to stop fentanyl from reaching the brain. The treatment trains the immune system to recognize fentanyl and various dangerous designer drug variants. Human clinical trials began in 2026.

    What's confirmed:

    • The experimental vaccine is designed to block fentanyl from reaching the brain.
    • Human clinical trials for the vaccine began in 2026.

    Still unconfirmed:

    • The vaccine trains the immune system to recognize a broad range of fentanyl-related designer drugs.
    • The vaccine could save thousands of lives per year.
    confidence 90%

  4. Experimental Fentanyl Vaccine Shows Promise in Early Human Trials

    ARMR Sciences is developing an experimental vaccine designed to block fentanyl from reaching the brain. Early-stage human trials indicate the vaccine can produce an immune response to prevent overdoses. It may also adapt to combat emerging synthetic drug analogs.

    What's confirmed:

    • ARMR Sciences is developing a vaccine to produce an immune response against fentanyl in humans.
    • Early-stage human trials of the experimental fentanyl vaccine have shown promise.
    • The vaccine aims to prevent overdoses by blocking the drug from reaching the brain.
    • The countermeasure is designed to adapt to emerging drug analogs and black-market drugs.

    Still unconfirmed:

    • The University of Houston is developing a vaccine that blocks opioids in animals.
    • The vaccine could leave users feeling nothing.
    confidence 90%